TFAP2B and polycystic kidney disease: Interestingly, in Char Syndrome patients, hypomorphic mutations in TFAP2B result in congenital heart defect, whereas a complete deletion of the mouse ortholog, AP-2β, leads to polycystic kidney disease due to excessive apoptosis of renal epithelial cells [14, 18].